Coffee increased in response to treatment of hepatitis C:

Advanced chronic liver disease hepatitis C during treatment may benefit from drinking coffee, according to a new study published in Gastroenterology, the American Gastroenterological Association, the official journal of the Institute patients Tuesday .

Studies show that patients receiving pegylated interferon and ribavirin therapy who, who drank three or more cups of coffee a day, twice more than non-drinkers reaction treatment.

In non-drinkers, 46 percent of early virological response; have 26 percent to 20 weeks did not detect serum hepatitis C virus (HCV) RNA, 48 percent of 22 weeks was not detected when To serum; and 11 percent had a sustained virologic response. On the contrary, for those who drank three or more cups of coffee a day, the corresponding rates were 73 percent, 52 percent, 49 percent and 26 percent, respectively.

"Coffee intake and liver enzyme levels have been low, reducing the incidence of chronic liver disease and liver cancer rate decreased progress, " said Neil Friedman, o, the National Cancer Institute and principal author of the study. "Although we observed between coffee intake viral response to treatment and independent association, the association needs to be copied in other studies. "

About 70 to 80 percent of individuals exposed to HCV become chronically infected. Worldwide, the estimated number of people in the 130 and 170 million U.S. dollars. Higher coffee consumption compared with the slow progress of the pre-existing liver disease and liver cancer risk reduction. However, anti-HCV therapy and response relationship has not been previously assessed.

Posted in: Coffee increased in response to treatment of hepatitis C: